MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies.
about
Discovery and validation of urinary biomarkers for prostate cancerClinical utility of endorectal MRI-guided prostate biopsy: preliminary experienceValue of enhanced transrectal ultrasound targeted biopsy for prostate cancer diagnosis: a retrospective data analysis.Repeat prostate biopsy strategies after initial negative biopsy: meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy.Advancements in magnetic resonance-guided robotic interventions in the prostate.D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging.3T MR-guided in-bore transperineal prostate biopsy: A comparison of robotic and manual needle-guidance templatesSimultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: early results of a phase I NCI study.Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion deviceProstate cancer magnetic resonance imaging (MRI): multidisciplinary standpoint.Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy.Development and preliminary evaluation of a motorized needle guide template for MRI-guided targeted prostate biopsy.Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen.Fully Automated Prostate Magnetic Resonance Imaging and Transrectal Ultrasound Fusion via a Probabilistic Registration Metric.Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology.Imaging modalities for prostate cancer.Technologies for localization and diagnosis of prostate cancer.Predictive value of MRI in the localization, staging, volume estimation, assessment of aggressiveness, and guidance of radiotherapy and biopsies in prostate cancer.Prebiopsy magnetic resonance spectroscopy and imaging in the diagnosis of prostate cancer.MRI-guided biopsy for prostate cancer detection: a systematic review of current clinical results.Recent advances in image-guided targeted prostate biopsy.Current trends and new frontiers in focal therapy for localized prostate cancer.Pros and cons of focal therapy for localised prostate cancer.In-bore magnetic resonance-guided transrectal biopsy for the detection of clinically significant prostate cancer.Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner.The accuracy and safety aspects of a novel robotic needle guide manipulator to perform transrectal prostate biopsies.Urinary proteome analysis for prostate cancer diagnosis: cost-effective application in routine clinical practice in Germany.3-T in-bore MR-guided prostate biopsy based on a scoring system for target lesions characterization.MRI-guided core needle biopsy of the prostate: acceptance and side effects.Design of a predictive targeting error simulator for MRI-guided prostate biopsy.Comparison of prostate MRI-3D transrectal ultrasound fusion biopsy for first-time and repeat biopsy patients with previous atypical small acinar proliferationMRI-directed cognitive fusion-guided biopsy of the anterior prostate tumors.High-risk prostate cancer: value of multi-modality 3T MRI-guided biopsies after previous negative biopsies.[Fusion imaging in urology: combination of MRI and TRUS for detection of prostate cancer].Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla.Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard.Molecular imaging and fusion targeted biopsy of the prostate.Incremental value of transition zone and midline apical biopsy at baseline TRUS-guided biopsy for prostate cancer detection.Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer.The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer.
P2860
Q30438582-CF1370B3-A05E-4C5E-9B8E-0AE16F1BC8AFQ33763838-4A5B448C-C63B-4438-AC34-CF348A14BD89Q34104689-811FA5AE-8902-4F39-BD6F-17EB6E45541AQ34608622-76407BF0-2E89-4A8F-AE32-40FB23E8941DQ34997228-6E27A3E1-3164-4080-BBA8-42892DE9E6F7Q35202301-84A43C88-2035-43A6-B00A-CB179549A45EQ35224636-FF4266A6-BC97-4BF2-B7B2-F309D59150D2Q36138138-D859324E-27D9-4A93-819D-A6CD747D5509Q36579232-445F1F6F-8A36-4FF5-AC9D-2A8772C7C123Q36795496-C66C5245-DF73-4B41-B1E3-A44F8D05672AQ37052521-F3AFB438-ABFD-4B0B-8E4D-E56A7B24629BQ37185395-8E1BF99D-971E-4751-9A4C-6E791022CF68Q37381526-12DD9E5E-AA59-40A7-9862-2FA18A7D3867Q37396739-77AADB71-37E9-478B-99A4-101C9F62C4F0Q37541876-057A435B-3EE6-492A-B212-DC41EDF4FE47Q37546036-D3FA0984-A1CC-4027-AB03-222BC3A23DFBQ37619516-CD7EE6B8-E82C-436E-96D4-40843EEA3632Q37968978-A273DF55-265D-45A1-BF73-DA961274B1C9Q37995646-42EF63E8-AB7A-43E7-871A-759463B1ECF5Q38097378-FABCCE3E-A9B0-436B-9AAA-0D823AA13795Q38321884-1094B6BB-4D7A-4033-B6DC-CE5D9784D003Q38436625-AD1DE8D3-699D-4939-8253-84B74D4D17A0Q38807805-8C43D6E7-2E3D-404E-A423-FF2503F68554Q39001746-F6AEFE27-FD37-493F-9D16-40A795737F04Q39816598-3474770A-29A1-47C9-97D1-306550B2F9ECQ39825491-2AC6114B-D642-43BC-93FE-1290F4A175A8Q40008598-78052A7A-4ABE-4261-8D53-3407FA6CD0B9Q40126185-B7707021-7BEB-4167-89D4-5AE529413B8AQ40161361-EE64BFD9-B218-4B1C-A1B5-D22945FC79D5Q41342416-809492A4-8775-408E-A663-7C9780EF49A0Q41614966-133F1076-78C3-491E-867C-97F8E8E61BC9Q41829707-90E7EFF1-D8A6-4C2A-9755-3DDAC9303B51Q42001579-A5BCC9F2-C8E7-420A-A28C-7CB8AB80E2ECQ43871415-DBA5D954-D4BF-406B-848D-07CE15A69E63Q44248079-8F2ADBA2-A27F-4CCB-BB5C-5918578E0459Q45826149-DE5361BD-87A2-4A59-8843-9A3D5C818F2CQ47608215-3EF3093D-CA2E-4437-9AB0-14361D3857A1Q47966967-57876F2C-1A44-46A7-A4D4-AD2C88109CB2Q48147412-59469C53-C991-4F8B-A083-C9FC26B39EF5Q50088856-FDD5B27B-6892-4E52-9BDE-8DA313BBD416
P2860
MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
MRI-guided biopsy of the prost ...... evious negative TRUS biopsies.
@en
MRI-guided biopsy of the prost ...... evious negative TRUS biopsies.
@nl
type
label
MRI-guided biopsy of the prost ...... evious negative TRUS biopsies.
@en
MRI-guided biopsy of the prost ...... evious negative TRUS biopsies.
@nl
prefLabel
MRI-guided biopsy of the prost ...... evious negative TRUS biopsies.
@en
MRI-guided biopsy of the prost ...... evious negative TRUS biopsies.
@nl
P2093
P1433
P1476
MRI-guided biopsy of the prost ...... evious negative TRUS biopsies.
@en
P2093
Aristotelis G Anastasiadis
Arnulf Stenzl
Axel S Merseburger
Claus D Claussen
Heinz-Peter Schlemmer
Joerg Hennenlotter
Karl-Dietrich Sievert
Markus A Kuczyk
Matthias P Lichy
Stefan Corvin
P304
738-48; discussion 748-9
P356
10.1016/J.EURURO.2006.03.007
P407
P577
2006-03-24T00:00:00Z